Leathem S. Stearn - 23 Sep 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
Director
Signature
/s/ Dale S. Bergman as attorney-in-fact for Leathem Stearn
Issuer symbol
ZEOX
Transactions as of
23 Sep 2022
Net transactions value
$0
Form type
3
Filing time
06 Oct 2022, 19:29:46 UTC
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OCEL Common Stock, $0.001 par value 666,667 23 Sep 2022 Direct
holding OCEL Common Stock, $0.001 par value 12,500,000 23 Sep 2022 Held by Stearn Enterprises LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCEL Warrants to Purchase Common Stock 23 Sep 2022 Common Stock, par value $0.001 per share 1,000,000 $0.0441 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the sole beneficial owner of Stearn Enterprises, LLC.
F2 The Warrants vest in 12 monthly installments of 83,333 shares commencing on September 23, 2022.

Remarks:

Exhibit List - Exhibit 24 Power of attorney